Login
Super Investors Artal Group S.A.
AG

Artal Group S.A.

Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.

Portfolio value
$687M
Positions
3
Quarter ended
September 30, 2026
Filed
November 12, 2026

Reported portfolio value by quarter (54 quarters reported)

$7.99B $687M
Q2 13 Q1 16 Q4 18 Q3 21 Q2 24 Q3 26

$3.18B in Q2 2013 → $687M now. Hover for any quarter.

Holdings

As reported for the quarter ended September 30, 2026. Activity is the change in share count since the prior quarter's filing.

Holding % of portfolio Activity Shares Value
Cava Group Inc 51.3% Unchanged 6,507,990 $352M
Lexicon Pharmaceuticals Inc 48.0% Unchanged 175,156,062 $329M
Iqm Quantum Computers Oyj 0.8% New 500,000 $5.19M

Timeline of changes

What changed each quarter, from the filings' own share counts. Largest moves first; most recent 8 quarters.

Q3 2026

quarter ended September 30, 2026 · filed November 12, 2026

Company Action Shares changed Value of change % of portfolio
Iqm Quantum Computers Oyj New +500,000 +$5.19M 0.8%

Q2 2026

quarter ended June 30, 2026 · filed August 13, 2026

Company Action Shares changed Value of change % of portfolio
Cava Group Inc Trimmed −3,000,000 −$235M 54.9%
Lexicon Pharmaceuticals Inc Added +20,421,735 +$49M 45.1%

Q1 2026

quarter ended March 31, 2026 · filed May 14, 2026

Company Action Shares changed Value of change % of portfolio
Lexicon Pharmaceuticals Inc Added +18,553,846 +$28.9M 23.9%

Q4 2025

quarter ended December 31, 2025 · filed February 12, 2026

No position changes this quarter.

Q3 2025

quarter ended September 30, 2025 · filed November 12, 2025

No position changes this quarter.

Q2 2025

quarter ended June 30, 2025 · filed August 13, 2025

No position changes this quarter.

Q1 2025

quarter ended March 31, 2025 · filed May 14, 2025

No position changes this quarter.

Q4 2024

quarter ended December 31, 2024 · filed February 14, 2025

Company Action Shares changed Value of change % of portfolio
Cava Group Inc Trimmed −8,000,000 −$902M 91.4%

Create Account

Sign up for free to unlock this feature.

Already have an account? Sign in

Premium Feature

This feature requires a premium subscription to unlock unlimited historical data and advanced analysis tools.

Premium includes:

  • Unlimited historical financial data
  • Advanced analytics and insights
  • Priority support